Splenic vein thrombosis
ICD-10 D73.5 · ICD-11 DB98.4

Splenic Vein Thrombosis with Severe Renal Impairment: When Initial Anticoagulation Fails to Achieve Vessel Recanalization

This protocol addresses the escalation step for symptomatic acute splanchnic vein thrombosis in patients with creatinine clearance below 30 mL/min who have not achieved adequate vessel recanalization on initial anticoagulant therapy.

Clinical Scenario

Symptomatic acute splanchnic vein thrombosis with creatinine clearance below 30 mL/min. The primary treatment goal is to achieve the highest possible vessel recanalization, thereby reducing splanchnic hypertension and bleeding risk.

Prior Treatment — Failure Condition

Initial treatment with unfractionated heparin, apixaban, rivaroxaban, or half therapeutic dose LMWH — with unfractionated heparin preferred when creatinine clearance falls below 15 mL/min — has not achieved the target of highest possible vessel recanalization. This protocol describes the management step taken after that failure.

Next-Step Approach (Partial Overview)

In very selected patients whose condition has not responded to initial anticoagulation, a thrombolytic intervention in a specialised centre may be considered. The full patient-selection criteria, treatment pathway, and structured regimen are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jth.14836

In patients with symptomatic acute splanchnic vein thrombosis and creatinine clearance <30 mL/min, we recommend initial treatment with unfractionated heparin, apixaban, rivaroxaban, or half therapeutic dose LMWH; we suggest unfractionated heparin if creatinine clearance <15 mL/min.

In patients with symptomatic acute splanchnic vein thrombosis we recommend against the routine use of systemic or catheter-directed thrombolysis. We suggest considering the use of thrombolysis in specialized centers for very selected patients such as those with mesenteric or extensive splanchnic vein thrombosis and signs of intestinal ischemia, or those whose conditions deteriorate despite adequate anticoagulant therapy.

Treatment of occlusive or non-occlusive acute splanchnic vein thrombosis aims to prevent intestinal infarction or ischemia, and achieve the highest possible vessel recanalization to reduce splanchnic hypertension and bleeding risk.

View source ↗